MTB
ALXN

Mizuho Trust & Banking’s Alexion Pharmaceuticals ALXN Stock Holding History

Mizuho Trust & Banking’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-356,327
Closed -$43.7M – 736
2016
Q3 		$43.7M Sell
356,327
-315
-0.1% -$40.5K 0.13% 175
2016
Q2 		$41.6M Buy
356,642
+6,770
+2% +$961K 0.13% 178
2016
Q1 		$48.7M Buy
349,872
+7,938
+2% +$1.17M 0.15% 148
2015
Q4 		$65.4M Buy
341,934
+7,860
+2% +$1.37M 0.22% 106
2015
Q3 		$52.2M Buy
334,074
+17,757
+6% +$3.24M 0.18% 129
2015
Q2 		$57.2M Buy
316,317
+37,584
+13% +$6.49M 0.19% 121
2015
Q1 		$48.3M Buy
278,733
+15,353
+6% +$2.78M 0.16% 138
2014
Q4 		$48.7M Buy
263,380
+15,232
+6% +$2.82M 0.17% 128
2014
Q3 		$41.3M Sell
248,148
-13,769
-5% -$2.26M 0.16% 145
2014
Q2 		$40.9M Sell
261,917
-962
-0.4% -$152K 0.15% 156
2014
Q1 		$40M Sell
262,879
-7,101
-3% -$1.13M 0.15% 155
2013
Q4 		$36.7M Buy
269,980
+1,637
+0.6% +$196K 0.14% 167
2013
Q3 		$24.8M Hold
268,343
– – 0.1% 235
2013
Q2 		$24.8M Buy
+268,343
New +$25.9M 0.1% 233

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Mizuho Trust & Banking's ALXN Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Alexion Pharmaceuticals (ALXN) in Q4 2016, closing a stake of 356,327 shares — an estimated $43.7M sold.

Mizuho Trust & Banking first reported a position in ALXN in Q2 2013 and held it in 14 quarters. The position peaked at $65.4M in Q4 2015. 548 funds tracked by Wall St. Rank hold ALXN as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Alexion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 356,327 Alexion Pharmaceuticals shares in Q4 2016, an estimated $43.7M.
  • Mizuho Trust & Banking first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's Alexion Pharmaceuticals position peaked at $65.4M in Q4 2015.
  • 548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.